Compare Logitech International SA (LOGI) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Logitech International SA vs Tilray Brands Inc — how do they compare? Logitech International SA trades at $98.27 (market cap $14.46B), while Tilray Brands Inc trades at $3.54 (market cap $530.54M). The key difference: Logitech International SA is far larger — about 27.3× Tilray Brands Inc's market cap, and Logitech International SA pays a 1.63% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Logitech International SA for 92 Days and Tilray Brands Inc for 31 Days on average.
| LOGI | TLRY | |
|---|---|---|
Market Cap | $14.46B | $530.54M |
Volume | 349,547 | 9,099,075 |
Sector | Technology | Health |
52-Week High | $126.69 | $21.00 |
52-Week Low | $85.84 | $3.57 |
Typical Hold Time | 92 Days | 31 Days |
Enterprise Value | $12.79B | $684.46M |
Dividend Yield | 1.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Logitech (LOGI) trades at $98.27, down 3.83% over the past day, amid a neutral technical backdrop. The stock shows strong fundamental health with consistent earnings beats, a robust net income margin of 16.28%, and a forward P/E of 18.64. Recent product launches, including the Zone Vibe Pro headset and MX Keypad, highlight innovation in the hybrid work and gaming segments. Cash flow trends are positive, with 2026 operating cash flow projected at $1.1 billion, supporting dividend payments and growth initiatives.
The investment outlook is balanced. Upside is supported by solid profitability, strategic partnerships like the SEGA alliance, and analyst consensus target of $107. However, risks include competitive pressures in peripherals, sensitivity to consumer spending, and the stock's high P/B ratio of 6.18. Investor sentiment is mixed, with technical indicators neutral and analyst ratings evenly split between buy, hold, and sell.
TLRY trades at $3.54, down 4.71% on the day and near 52-week lows, reflecting persistent bearish sentiment. The stock shows negative technical momentum with consecutive earnings misses and widening losses despite revenue growth. Recent financials reveal a net loss of $2.19B for 2025, though analyst consensus maintains a $65.01 price target with 25% buy ratings. Business developments include new product launches and leadership changes under Tilray's expanded beverage portfolio.
Outlook remains challenged by profitability concerns and high debt, but potential cannabis regulatory shifts could catalyze recovery. Investment opportunity hinges on execution improvement and market expansion, while risks include sustained cash burn and competitive pressures in the cannabis sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Logitech International SA
Logitech International SA is a Switzerland-based provider of personal computer and mobile accessories for navigation, video communication, and collaboration, smart home, and other applications. Its product portfolio includes mice, keyboards, charging stands, tablet cases, car mounts for mobile devices, remotes, home cameras, home switches, controllers, bluetooth speakers, surround sound, webcams, and conference cameras. It operates in a single segment namely, Peripherals. The firm generates revenue from the Americas, EMEA (Europe, Middle East, Africa), and the Asia Pacific region.
Read more on LOGI →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
